skip to main content
Show Results with:

Results 1 - 10 of 82  for Everything in this catalogue

results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Managing the toxicities of CAR T‐cell therapy

Neelapu, Sattva S.

Hematological oncology. Volume 37 (2019) Supplement 1; pp 48-52 -- John Wiley & Sons

Online access

2
Material Type:
Article
Add to My workspace

Managing the toxicities of CAR T‐cell therapy

Neelapu, Sattva S.

Hematological oncology. Volume 37: (2019, June); pp 48-52 -- John Wiley & Sons

Online access

3
Material Type:
Article
Add to My workspace

CAR-T efficacy: is conditioning the key?

Neelapu, Sattva S.

Blood. Volume 133:Number 17 (2019, April 25th); pp 1799-1799 -- Grune and Stratton

Check library holdings

4
Material Type:
Article
Add to My workspace

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function

Chu, Fuliang; Neelapu, Sattva

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

5
Material Type:
Article
Add to My workspace

Cancer immunotherapy: Strategies for personalization and combinatorial approaches

Sathyanarayanan, Vishwanath; Neelapu, Sattva S.

Molecular oncology -- Elsevier on behalf of the Federation of European Biochemical Societies -- Volume: 9 10; (pages 2043-2053) -- 2015

Online access

6
Material Type:
Article
Add to My workspace

The promise of CAR T-cell therapy in aggressive B-cell lymphoma

Nair, Ranjit; Neelapu, Sattva S.

Baillière's best practice and research in clinical haematology. Volume 31:Number 3 (2018, September); pp 293-298 -- Elsevier Ltd

Online access

7
Material Type:
Article
Add to My workspace

The promise of CAR T-cell therapy in aggressive B-cell lymphoma

Nair, Ranjit; Neelapu, Sattva S.

Baillière's best practice and research in clinical haematology. Volume 31:Issue 3 (2018, September); pp 293-298 -- Elsevier Ltd

Online access

8
Material Type:
Article
Add to My workspace

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1+ T-cell subsets

Chu, Fuliang; Neelapu, Sattva S

Oncoimmunology -- Taylor & Francis -- Volume: 3 Issue: 3; -- 2014

Online access

9
Material Type:
Article
Add to My workspace

Cancer immunotherapy: Strategies for personalization and combinatorial approaches1

Sathyanarayanan, Vishwanath; Neelapu, Sattva S.

Molecular oncology. Volume 9:Issue 10 (2015); pp 2043-2053 -- FEBS Press and John Wiley & Sons Ltd

Online access

10
Material Type:
Article
Add to My workspace

Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma

Cheah, Chan Yoon; Fowler, Nathan H.; Neelapu, Sattva S.

Current opinion in oncology. Volume 27:Issue 5 (2015, September) -- Wolters Kluwer Health, Inc

Online access

Results 1 - 10 of 82  for Everything in this catalogue

results 1 2 3 4 5 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (69)
  2. Online: Reading Room only  (52)
  3. Purchase a copy  (37)
  4. Refine further open sub menu

Creation date 

From To
  1. Before2014  (2)
  2. 2014To2014  (6)
  3. 2015To2015  (12)
  4. 2016To2017  (27)
  5. After 2017  (35)
  6. Refine further open sub menu

Additional Features 

  1. Abstract  (57)
  2. No Abstract  (25)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait